Medical Assistant

PARDEEP M. BHATIA, PhD

** ******** ***, **********, **

06032

Home: 860-***-**** . Email: *****@*******.***

VISA STATUS

US CITIZEN

OBJECTIVE

Seeking a Medical Writer/Grant Writer Position in a CME or a Pharmaceutical

company or in academia that requires advanced knowledge of

scientific/clinical oncology, basic statistics, business acumen, strategic

publication planning and superior verbal and written communication skills.

EXECUTIVE SUMMARY

An accomplished Biomedical Scientist and Medical/Grant Writer with advanced

knowledge in Oncology/Immunology, Biomedical Sciences, Molecular Biology,

Cell and Tumor Biology, CNS, Endocrinology, Virology and basic statistics

etc. Proficiency in business acumen, publication planning and development.

Knowledge of AMA and scientific writing style and familiarity with IND and

NDA and CSR. Self-motivated, enthusiastic, superior interpersonal and

verbal/written communication skills. Ability to act as a conduit between

thought leaders and company. Proven ability in dissemination of scientific

information, review of scientific material, scientific writing technical

presentations, organizing ability, teamwork and excellent computer skills

both in Mac and Windows environment.

EXPERIENCE HIGHLIGHTS

Writing Skills:

. Fifteen years experience in medical, clinical and technical writing and

publication planning and development in oncology and biomedical sciences.

. Wrote about 8 grants on gene cloning, bone metastasis of breast carcinoma

and retroviral insertional mutagenesis at the various institutes such as

University of Glasgow, UK, Manitoba Institute of Cell Biology, Winnipeg

Canada, Mayo Clinic, USA, and University of Connecticut Health center.

. Authored 16 papers, 6 clinical documents, 8 needs assessments and CME

grants and equal number of abstracts and posters in peer reviewed

journals and symposia.

Oral Communication Skills:

. Effectively communicate research findings to faculty, students and staff

in the last fifteen years. Participated and presented in five

international scientific meetings. Received a travel award from Key Stone

Symposium on Bone Biology.

Manuscript Review and Poster Preparation:

. Reviewed several papers and PowerPoint presentations and posters while

working with Prof. Mark Hansen in Fels Institute of Cancer Research and

Uconn Health Center, Connecticut, USA since April 1998 till today and in

Manitoba Institute of Cell Biology, Winnipeg, Manitoba, Canada from

January 1990-Feb 2005.

Grant Review and Evaluation:

. Reviewed grants from NIH, ACS and NCI on cancer biology in Fels Institute

for Cancer Research and University of Connecticut Health Center,

Connecticut. (April 1998 till Feb 200) and at Manitoba Institute of cell

Biology, Canada. (January 1990 to September 1993).

Manuscript Review and Evaluation:

. Reviewed several papers and PowerPoint presentations and posters while

working with Prof. Mark Hansen in Fels Institute of Cancer Research and

Uconn Health Center, Connecticut, USA since April 1998 till today and in

Manitoba Institute of Cell Biology, Winnipeg, Manitoba, Canada from

January 1990-Feb 2005.

Awards Extramural Funding and Grants Submitted:

. Study of Expression of RANK and RANKL in Bone metastasis of Breast

(2005).

. Study of Different Subtypes of DCIS in Breast Cancer by Antibody

Microarrays (2005).

. Study of Osteolytic Metastatic phenotype in Bone Metastasis of Breast

by Antibody Microarrays.

. Concept award from the Department of Defense (DOD) Breast Cancer

Research Program for an extramural

funding (2000).

. Travel Award from the Keystone symposia for attending Molecular

Biology of Bone diseases (1999).

. Quintin Hogg Fellow at Royal College of Surgeons, London (1988 -

1989).

. Assistant Research Officer Department of Science and Technology, Govt.

of India, New Delhi, India

(1984 - 1986).

. Junior Research Fellow Council of Scientific and Industrial Research, New

Delhi, India (1981 - 1984).

Computer Skills: MS Word, Excel, PowerPoint, Adobe Photoshop, C/C++,

Oracle, Visual Basic.

PROFESSIONAL EXPERIENCE:

Medical Writer

Jun 2008 -Jul 2008

France Foundation, Old Lyme, CT

. Writing, editing and evaluating scientific manuscripts, papers and

abstracts.

. Planned, developed and wrote 6-8 needs assessments, and equal no of

abstracts.

Consultant

Apr 2007-Aug 2007

Strategic Health Care Services, Columbus, Ohio

. Writing, editing and evaluating scientific manuscripts and grants.

Senior Post Doctoral Fellow

Mar 1997-Feb 2005

University of Connecticut Health Center, Farmington, CT

Principal Investigator: Prof Marc Hansen, Ph.D.

. Investigated the role of TNF super family members RANK and RANKL in

Breast Cancer metastasis and

Osteosarcoma.

. Developed a novel breast cancer metastasis related diagnostic

biomarker, which has inverse relationship with metastatic phenotype

both in breast cancer as well as osteosarcoma.

. Trained and supervised technical and research staff.

. Planned developed and wrote 4 scientific proposals, 3 manuscripts and 4-

5 Power point presentations and posters.

Senior Post Doctoral Fellow

Mar 1996-Mar 1997

Mayo Clinic, Rochester, MN

Principal Investigator: Robert Jenkins

. Cloning and Isolation of Tumor Suppressor genes in Prostate Cancer.

. Planned developed and submitted three scientific proposals in one

year.

Post Doctoral Research Assistant

Sept 1993-Mar 1995

University of Glasgow, IBLS, UK, University of Glasgow, IBLS, UK

Principal Investigator: Joanna Wilson

. Role of Epstein Barr Virus Nuclear antigen 1 in Lymphoma in lymphomagenic

animals.

. Wrote one scientific proposal in one year

Research Associate

Jan 1990-Sept 1993

Manitoba Institute of Cell Biology, Winnipeg, Manitoba, Canada

Principal Investigator: Dr. Jim Wright

. Cloning of Metastasis Associated Genes.

. Planned developed and communicated one scientific proposal, reports for

NCI and one manuscript.

Quintin Hogg Fellow

Jul 1988- Jan 1990

Royal College of Surgeons of England, London, UK

Principal Investigator: Prof. Newel Johnson and Sidney Chang

. Studied myc and ras oncogenes in Oral Cancer.

. Planned developed and submitted one scientific manuscript

Post Doctoral Fellow

Feb 1986-Jul 1988

Aarhus University, Aarhus, Denmark

Principal Investigator: Prof. Brian F C Clark

. Studied cytokinins and their analogues for their antiaging and anticancer

activity.

. Planned developed and communicated two scientific manuscripts.

Studied Hematological malignancies, leukemias and stem cells

Sept 1984- Feb1986

All India Institute of Medical Sciences, New Delhi, India

Principal Investigator: Prof. Vinod Kochupillai

. Planned developed, wrote and submitted three scientific manuscripts.

Graduate Student Jul

1981-Jul 1984

Banaras Hindu University, Varanasi, India

Advisor: Dr Ajit Sodhi

Effect of cisplatin on Mouse macrophages

. Investigated the immunopotentiating activity of anticancer drug

cisplatin on mouse macrophages in vitro.

. Planned and submitted two scientific manuscripts.

EDUCATION

. Ph.D., Immunology-Oncology, Dept of Zoology, Banaras Hindu

University, Varanasi, India (1981-1985).

. Master of Science, (Hons. Sch.) Biology, Guru Nanak Dev University,

Amritsar, India (1980-1981).

. BS, (Hons. Sch.) Biology, Guru Nanak Dev University, Amritsar,

India (1978-1980).

_______________________________________________________________________

________________________________

PUBLICATIONS:

1. Bhatia, P., Sanders, M., and Hansen M.F. (2005) Expression of

RANKL is inversely related to bone metastatic phenotype in

breast cancer. Clin.Cancer.Res, 11:162-165.

2. Bhatia, P., Deshpande, A., Ammerman, D.G et al., (2007) .RANK is

Up regulated and Co-localizes with RANKL in Osteosarcoma Tumors

and Tumor Cell Lines (Under Preparation).

3. Drotar M., Silva, S., Barone, E., Campbell., D., Tsimbouri,

P., Jurvansuu., J., Bhatia, P., Klein, G., and Wilson, J B.

(2003) Epstein-Barr virus nuclear antigen-1 and myc cooperate in

lymphomagenesis. Int. J Cancer.106:388-395.

4. Johnson-Pais, T.L., Nellissery, M. J., Ammerman D.G,

Pathmanathan, D., Bhatia, P., et al., (2002). Determination of

Minimal Region of Loss of Heterozygosity on Chromosome 18q21.33

in Osteosarcoma. Int. J Cancer. 105: 285-288.

5. Hansen M F, Nellisery M J, Bhatia, P (1999). Common Mechanisms

of Osteosarcoma and Paget's disease. J Bone and Mineral Res. 14:

39-44.

6. Bhatia, P., Taylor, W.R., Greenberg, A.H. and Wright, J.A.

(1994). Comparison of Glyceraldehyde-3-phosphate dehydrogenase

and 28S-Ribosomal RNA gene expression as RNA loading controls

for Northern blot analysis of cell lines of varying malignant

potential. Anal. Biochem. 216: 223-226

7. Chang S.E, Bhatia, P., Johnson, N.W., Morgan, P.R., McCormick,

F., Young, B., and Hiorns, L. (1991) Ras mutations in United

Kingdom examples of oral malignancies are infrequent. Int. J.

Cancer. 48: 409-412.

8. Rattan, S.I.S., Rasmussen, L.M., Bjerring, P., Bhatia, P. and

Clark, B.F.C. (1988) Unaltered levels of plasma fibronectin in

Alzheimer's disease. J. Clin. Pathology. 41: 476.

9. Bhatia, P., Rattan, S.I.S., Cavallius, J. and Clark, B.F.C.

(1987). Withania sominifera (Aswagandha), a so-called

rejuvenator, inhibits growth and macromolecular synthesis of

normal human fibroblasts and HeLa cells. Med.Sci. Res., 15: 515-

516.

10. Rattan, S.I.S, Cavallius, J., Bhatia, P., and Clark, B.F.C

(1987) Protein Elongation factor-1a in ageing rodent brains: .In

AGEING-A Multifactorial Discussion Eds.Kullari Subha Rao and V.

Prabhakar, Association of Gerontology.

11. Rattan, S.I.S., Rasmussen, L.M., Bjerring, P., Bhatia, P. and

Clark, B.F.C. (1987). Human plasma fibronectin levels during

ageing, Alzheimer's disease and cancer. In: Advances in Age

Research (Eds. E. Steinhagen-Thiessen and D. Knook), TNO

Institute for experimental gerontology, Rijswick, The

Netherlands.

12. Rattan, S.I.S. and Bhatia, P. (1987). Genetic Engineering: Fact,

Fiction and Future. Indo-European Medical Journal (Denmark).2:

27-29.

13. Bhatia, P., Kochupillai, V., Mehra, N.K. et al. (1987). Studies

on engraftment following fetal liver infusion in aplastic anemia

and acute leukemia. Thymus. 10: 117-102.

14. Kochupillai, V., Subhadra, S., Francis, S., Nanu, A., Susan, M.,

Bhatia, P. et al. (1987). Fetal liver infusion in aplastic

anemia. Thymus. 10: 95-102.

15. Sodhi, A. and Bhatia, P. (1986). In vitro activation of murine

macrophages and their increased capacity to lyse target cells

after cis-Platin treatment. Ind. J. Exp. Biol., 24: 565-572.

16. Sharma, S.P. and Bhatia, P. (1982). Amino acid changes in ageing

Bruchids Zabrotes subfasciatus (coleoptera). Curr Sci, 51: 664-

665.

Additional writings:

Six "Needs Assessments", and equal no. of articles and abstracts

for the CME companies.

Selected Writings: (France Foundation, CT)

1. Bipolar Disorder (BP) throughout the Life Cycle: Treatments and

Treatment

2. Children's Epilepsy and Therapeutical management

3. Erythropoietin alfa (EPO) in Leukemia and Myelodysplastic Syndrome

(MDS)

4. Alzheimer's Disease, Diagnosis, Therapeutic Measures and Clinical

Management.

5. GARDASIL A NEW HOPE IN PRECANCEROUS AND HIGHGRADE CERVICAL CANCERS.

(CME CO)

6. Merck's ZOLINZA (vorinostat), Offers Hope for Advanced Cutaneous T-

Cell Lymphoma (CME CO)

7. Molecular techniques are the most reliable way of monitoring minimal

residual disease (MRD) in Chronic Myelogenous Leukemia. ( CME Company)

Communications in Scientific Conferences & Symposia: Fourteen in

National and International Meetings

Contact this candidate